semaglutide insulin resistance GLP-1 drugs such as and tirzepatide are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights A new shot lets diabetes

Zepbound's starting dose (2.5 mg) produces measurable weight loss in most patients

View Product What Are Retatrutide and Survodutide

On the contrary, a systematic review on mortality, as well as cardiovascular and kidney statuses in patients with T2DM treated with GLP-1RAs concluded that there was no increase in the incidence of severe hypoglycaemia, pancreatitis, or pancreatic cancer (222)

Bottom line Switching from semaglutide to tirzepatide can be a viable option for individuals seeking enhanced weight loss or improved glycemic control, or those who cannot tolerate semaglutide side effects

It's less common for Wegovy to be covered

Compounded Medication Disclaimer: Compounded semaglutide and compounded tirzepatide are not FDA-approved as finished drug products